|
2367
|
AM 095 (parent compound)
|
Novel potent and selective LPA1 antagonist |
€125.00 |
|
2368
|
Amuvatinib
|
RTK inhibitor which effectively inhibits PDGFR, c-Kit and c-Met |
€105.00 |
|
2500
|
Apilimod dimesylate
|
Cytokine inhibitor; IL-12 and IL-23 inhibitor |
€110.00 |
|
2185
|
BAM 7
|
Selective small-molecule activator of proapoptotic BAX |
€90.00 |
|
2356
|
BMS 833923
|
Oral antagonist of the Hedgehog signaling component Smoothened (SMO) |
€75.00 |
|
2161
|
CCT 031374 hydrobromide
|
Inhibitor of TCF-dependent transcription of genes of Wnt signaling pathway |
€60.00 |
|
2254
|
CP 101606
|
NMDA NR2B antagonist |
€120.00 |
|
2293
|
Ferrostatin 1
|
Potent inhibitor of erastin-induced ferroptosis |
€85.00 |
|
2348
|
GNE 7915
|
Potent, selective, metabolically stable, and brain-penetrable LRRK2 inhibitor |
€110.00 |
|
2363
|
GSK 2033
|
The first potent cell-active LXR antagonist |
€105.00 |
|
2354
|
Linagliptin
|
Competitive and highly selective dipeptidyl peptidase (DPP)-4 inhibitor |
€90.00 |
|
2362
|
LY 333531 hydrochloride
|
PKC-β inhibitor |
€75.00 |
|
2359
|
Nexturastat A
|
HDAC6 inhibitor with good selectivity over HDAC1 and HDAC8 |
€90.00 |
|
2370
|
SB-3CT
|
Potent and selective inhibitor of Gelatinases MMP-2 and MMP-9 |
€125.00 |
|
2369
|
UPF 1069
|
PARP-2 inhibitor with >26 fold selectivity over PARP1 |
€75.00 |